Recombinant Human CDO1 Protein，His

CDO1, or Cartilage Oligomeric Matrix Protein 1, is a member of the Cartilage Oligomeric Matrix Protein (COMP) family known to play a role in extracellular matrix organization and cellular signaling processes. The investigation of CDO1 recombination protein has gained significant attention due to its potential implications in various physiological and pathological processes, including cartilage development, tissue repair, and disease mechanisms such as osteoarthritis and cancer. Recent studies have highlighted the importance of CDO1 in regulating chondrocyte function and modulating inflammatory responses, suggesting a pivotal role in maintaining cartilage homeostasis. Furthermore, alterations in CDO1 expression and function have been linked to impaired regeneration and the progression of degenerative diseases, prompting researchers to explore its therapeutic potential. Understanding the structural and functional characteristics of CDO1, particularly through recombinant protein studies, could pave the way for innovative strategies in regenerative medicine and targeted therapies. These studies not only provide insights into CDO1's biological roles but also contribute to the broader understanding of extracellular matrix interactions within the cellular microenvironment. By utilizing techniques such as protein expression, purification, and functional assays, researchers aim to elucidate the mechanisms by which CDO1 contributes to tissue dynamics and disease pathology. This growing body of research underscores the significance of CDO1 as a critical player in matrix biology, offering new avenues for intervention in connective tissue disorders and enhancing our comprehension of molecular pathways involved in health and disease.